Sign in
4

Changes in Ownership

Eledon Pharmaceuticals, Inc. Filed Acc 0000899243-18-016652

Options or other derivatives

  • Director acquired 9,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
McBride John S. Director 2018-06-13 Grant or award · Stock Option (Right to Buy) +9,100 9,100 D: show line 1 in the form
Loading xslF345X03/doc4.xml…